Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis
Sojin Lee(Diabetes Australia), H. Henry Dong(University of Pittsburgh), Goma Chhetri(Diabetes Australia), Aatur D. Singhi(University of California, San Francisco), Taofeek O. Usman(Babraham Institute), Riley McConnell(Diabetes Australia), Cuiling Zhu(Diabetes Australia), Alejandro Soto–Gutiérrez(McGowan Institute for Regenerative Medicine), Satdarshan P. Monga(University of Pittsburgh Medical Center), Kyler Krantz(Diabetes Australia), Alina Ostrowska(University of Pittsburgh), Allan Tsung(University of Pittsburgh), Jon D. Piganelli(University of Pittsburgh), Dhivyaa Rajasundaram(University of Pittsburgh), Jingyang Gao(Diabetes Australia), Radhika Muzumdar(Diabetes Australia), Gina M. Coudriet(University of Pittsburgh), Jun Yamauchi(Diabetes Australia), Xingchun Wang(Diabetes Australia), Sucha Singh(University of Pittsburgh)
Cited by 57
Related Papers
Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology
|Annual Review of Pathology Mechanisms of Disease|2017|475
Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis
|Journal of Hepatology|2021|378
Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells
|The Journal of Immunology|2005|361
Conditional Deletion of β-Catenin Reveals Its Role in Liver Growth and Regeneration
|Gastroenterology|2006|356